"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
- Acute Spinal Cord Injury
- Acute Spinal Paralysis
- Spinal Cord Injuries
- Trauma, Spinal Cord
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- University of British Columbia
- Enrolment target
- 120
- Started
- 17 March 2023
- Main results due
- 30 December 2029
- Study sites
- 1
- Registry updated
- 23 September 2026
Can you take part?
- Aged 19 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria SCI Participants. Patients who suffer a traumatic spinal cord injury who meet the following inclusion criteria are eligible for admission into the study as "SCI participants": * Male or Female ≥ 19 years of age * Blunt (non-penetrating) traumatic spinal cord injury * Baseline neurologic impairment deemed "complete"(AIS A) or "incomplete" (AIS B, C, D) * Bony spinal level involvement between C0 and L1 inclusive * Ability to have initial blood sample drawn within 24 hours of injury * Have either an arterial line, central line, or intravenous line for collecting blood samples * Able and willing to provide informed consent Non-SCI Spine Trauma Control Participants. Patients who suffer a fracture or dislocation of their spinal column without neurologic injury who meet the following inclusion criteria are eligible for admission into the study as "Non-SCI Spine Trauma Control Participants": * Male or Female ≥ 19 years of age * Traumatic spinal fracture between C0 and L1 without spinal cord injury * Collection of initial blood sample within 24 hours of injury * Have either an arterial line, central line, or intravenous line for collecting blood samples * Able and willing to provide informed consent Exclusion Criteria Patients who fulfill any of the following criteria are not eligible for admission into the study: * Penetrating spinal cord injury (e.g. gunshot, stab) * Spinal cord injury with sensory deficit only (i.e. no motor deficit) * Spinal injury below L1 * Isolated radiculopathy without fracture * Isolated cauda equina injury * Pre-existing thromboembolic disease or coagulopathy (disorders related to blood clotting), such as haemophilia or von Willebrand's disease * Have any other medical condition that in the investigator's opinion would render the study procedures dangerous or impair their ability to receive treatment
What this study is about
In the sponsor’s own words, from the registry.
Prospective, single center study designed to assess blood biomarkers for classifying injury severity and predict neurologic recovery in traumatic spinal cord injured (SCI) patients.
Study will also establish the accuracy of point to care devices for SCI blood biomarkers and support the biospecimen collection for the International Spinal Cord Injury Biobank (ISCIB).
Study sites(1)
Vancouver General Hospital
Vancouver, British Columbia, Canada
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT05244408. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me